Advertisement

Brivaracetam good value for focal-onset seizures in Finland

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Notes

    1. 1.

      The study was funded by UCB Pharma Oy Finland.

    Reference

    1. Vaatainen S, et al. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland. Advances in Therapy : 5 Dec 2019. Available from: URL: https://doi.org/10.1007/s12325-019-01155-6

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Brivaracetam good value for focal-onset seizures in Finland. PharmacoEcon Outcomes News 844, 10 (2020). https://doi.org/10.1007/s40274-020-6473-6

    Download citation